Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate)

Frontiers in Bioscience

Volumn 11, Issue 1 P.447-888, 2006, Pages 498-501

  De Chiara, Annarosaria ^a   De Rosa, Vincenzo ^a   Lastoria, Secondo ^a   Franco, Renato ^a   Botti, Gerardo ^a   Iaffaioli, Vincenzo Rosario ^a   Apice, Gaetano ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

GIST; Gleevec; Liver; Lung Metastases; Malignant

Indexed keywords

EID: 32944458806     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1813     Document Type: Article

References (18)

1. Fletcher CDM, J.J. Herman, C. Corless, F. Gorstein, J. Lasota, B.J. Longley, M. Miettinen, T.J. O'Leary, H. Remotti, B.P. Rubin, B. Shmookler, L.H. Sobin & S.W. Weiss: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 3, 459-465 (2002)
2. Demetri GD, M. von Mehren, C.D. Blanke, A.D. Van den Abbeele, B. Eisenberg, P.J. Roberts, M.C. Heirinch, D.A. Tuveson, S. Singer, M. Janicek M, J.A. Fletcher, S.G. Silverman, S.L. Silberman, R. Capdeville, B. Kiese, B. Peng, S. Dimitrijevic, B.J. Druker, C. Corless, C.D.M Fletcher & H. Joensuu: Efficacy and safety of Imatinib Mesylate in advanced gastrointestinal stromal tumor. N Engl J Med 347, 472-480 (2002)
3. Miettinen M, M. Sarlomo-Rikala, L.H. Sobin & J. Lasota: Esophageal stromal tumors: A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 24, 211-222 (2000)
4. Trupiano JK, R.E. Stewart, C. Misick, H.D. Appelman & J.R. Goldblum: Gastric stromal tumors: A clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol 26, 705-714 (2002)
5. Miettinen M, J. Kopczynski, H.R. Maklouf, M. Sarlomo-Rikala, H. Gyorffy, A. Burke, L.H. Sobin & J. Lasota: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinical, pathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 27, 625-641 (2003)
6. Miettinen M, Sarlomo-Rikala M, Sobin LH & J. Lasota: Gastrointestinal stromal tumors and sarcoma in the colon: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 24, 1339-1352 (2000)
7. Miettinen M, M. Furlong, M. Sarlomo-Rikala, A. Burke, L.H. Sobin & J. Lasota: et al: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: A clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 25, 1121-1133 (2001)
8. Miettinen M & L.H. Sobin: Gastrointestinal stromal tumors in the appendix: A clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol 25, 1433-1437 (2001)
9. Reith JD, J.R. Goldblum, R.H. Lyles & S.W. Weiss: Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 13, 577-585 (2000)
10. Mendoza-Marin M, M.P. Hoang & J. Albores-Saavedra: Malignant stromal tumor of gallbladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med 126, 481-483 (2002)
11. Hu X, J. Forster & I. Damjanov: Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med 127, 1606-1608 (2003)
12. Wang X, I. Mori, W. Tang, et al: Gastrointestinal stromal tumor: are they of Cajal cell origin? Exp Mol Pathol 72, 172-177 (2002)
13. Kindblom L-G, H.E. Remotti, F. Aldenborg & J.M. Meis- Kindblom: Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152, 1259-1269 (1998)
14. Sjoblom T, A. Shimizu, K.P. O'Brien, K. Pietras, P. Dal Cin, E. Buchdunger, J.P. Dumanski, A. Ostman & C.H. Heldin: Growth inhibition of dermatofibrosarcoma protuberans tumors by platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 61, 5778-5783 (2001)
15. Mc Arthur G: Molecularly targeted treatment for dermatofibrosarcoma protuberans. Semin Oncol 31, 30-36 (2004)
16. Hornick JL & C.D.M. Fletcher: Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 117, 188-193 (2002)
17. Miettinen M, M. Sarlomo-Rikala & J. Lasota: KIT expression in angiosarcomas and fetal endothelial cells: Lack of mutations of exon 11 and exon 17 of c-kit. Mod Pathol 13, 536-541 (2000)
18. Hornick JL & C.D.M. Fletcher: The significance of KIT (CD117) in gastrointestinal stromal tumors. Int J Surg Pathol 12, 93-97 (2004)